Top six takeaways from the 2026 Danaher Summit
The old manufacturing playbook no longer fits. Biomanufacturing was built for large batches of standardized therapies. The next generation of medicines—cell and gene therapies, targeted and complex biologics, n-of-1 treatments—doesn't fit t…